Polyhedral boron compounds as potential diagnostic and therapeutic antitumor agents.
The use of polyhedral boron hydrides for cancer treatment is traditionally connected with boron neutron capture therapy. More recently, polyhedral borate anions were proposed as carriers of radionuclide label for targeted radionuclide therapy and diagnostics of cancer. Some metal derivatives of carboranes were found to demonstrate significant antitumor activity themselves. This review is designed to highlight the recent work concerning various fields of potential application of polyhedral boron compounds in anticancer diagnostics and therapy.
Bregadze
V I
VI
A.N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, Moscow, Russia. bre@ineos.ac.ru
Sivaev
I B
IB
Glazun
S A
SA
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001880:Boranes / Q000493:pharmacokinetics / Q000627:therapeutic use; D001896:Boron Compounds / Q000627:therapeutic use*; D016754:Boron Neutron Capture Therapy / Q000379:methods; D045744:Cell Line, Tumor; D006801:Humans; D009369:Neoplasms / Q000175:diagnosis* / Q000188:drug therapy* / Q000532:radiotherapy
D000970:Antineoplastic Agents; D001880:Boranes; D001896:Boron Compounds